Commission Delegated Regulation (EU) 2018/729 of 26 February 2018 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances (Text with EEA relevance. )
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Amendment to Regulation (EC) No 273/2004
In Annex I to Regulation (EC) No 273/2004, in the table for Category 1 scheduled substances, the following entries are inserted in the list of substances in the appropriate place sequentially according to their CN Code: Substance CN designation (if different) CN code CAS No β4-anilino- N -phenethylpiperidine (ANPP) Β 2933Β 39Β 99 21409-26-7 N -phenethyl-4-piperidone (NPP) Β 2933Β 39Β 99 39742-60-4β.
Amendment to Regulation (EC) No 111/2005
In the Annex to Regulation (EC) No 111/2005, in the table for Category 1 scheduled substances, the following entries are inserted in the list of substances in the appropriate place sequentially according to their CN Code: Substance CN designation (if different) CN code CAS No β4-anilino- N -phenethylpiperidine (ANPP) Β 2933Β 39Β 99 21409-26-7 N -phenethyl-4-piperidone (NPP) Β 2933Β 39Β 99 39742-60-4β.
Entry into force and application
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 7Β July 2018.
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.